Skip Nav Destination
1-20 of 20
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Establishment and Utilization of an Advanced Practice Provider-Led Clinic for Newly Diagnosed Venous Thromboembolism
Blood (2022) 140 (Supplement 1): 7887–7888.
Harish Eswaran, MD, Jamie Jarmul, MDPhD, Amy Shaheen, MDMSc, David Meaux, BA, Tristan Long, MBA, Derek Saccoccio, MBA, Stephan Moll, MD
Blood (2020) 136 (Supplement 1): 31–32.
Blood (2020) 136 (13): 1487–1498.
Incidence and Time Course of Neutropenia in Patients Treated with Rituximab-Based Therapy for Non-Malignant Immune-Mediated Hematologic Diseases
Luis E Malpica Castillo, MD, Shannon Palmer, MS, Allison Deal, MS, Sheh-Li Chen, PharmD, Anqi Zhu, MS, Stephan Moll, MD
Blood (2019) 134 (Supplement_1): 390.
Adherence to Infectious Disease Screening and Immunization Guidelines When Treating Non-Malignant Immune-Mediated Hematologic Disorders
Luis E Malpica Castillo, MD, Shannon Palmer, MS, Anqi Zhu, MS, Allison Deal, MS, Sheh-Li Chen, PharmD, Stephan Moll, MD
Blood (2019) 134 (Supplement_1): 792.
Recombinant Porcine Factor VIII Use in Bleed Treatment in Non-Severe Hemophilia a Inhibitor Patients: Dosing Strategies and Efficacy
Patrick Ellsworth, MD, Sheh-Li Chen, PharmD, Yasmina L. Abajas, MD, Stephan Moll, MD, Nigel S. Key, MBChB, FRCP, Alice D. Ma, MD
Blood (2018) 132 (Supplement 1): 1202.
Antiphospholipid antibodies and recurrent thrombosis after a first unprovoked venous thromboembolism
Clinical Trials & Observations
Clive Kearon, Sameer Parpia, Frederick A. Spencer, Trevor Baglin, Scott M. Stevens, Kenneth A. Bauer, Steven R. Lentz, Craig M. Kessler, James D. Douketis, Stephan Moll, Scott Kaatz, Sam Schulman, Jean M. Connors, Jeffrey S. Ginsberg, Luciana Spadafora, Vinai Bhagirath, Patricia C. Liaw, Jeffrey I. Weitz, Jim A. Julian
Blood (2018) 131 (19): 2151–2160.
Includes: Supplemental data
Treatment of Venous Thromboembolism in Patients with Hematological Malignancies and Severe Thrombocytopenia: A Retrospective Cohort Analysis
Damon E. Houghton, MD, Jeffrey P. Laux, PhD, Nigel S. Key, MB, ChB, FRCP,, Neil A Zakai, MD MSc, Thomas C. Shea, MD, Stephan Moll, MD
Blood (2016) 128 (22): 531.
Blood (2013) 122 (21): 2385.
Identification of Patients At High Risk for Recurrent Venous Thromboembolism by Whole Blood Gene Expression Analysis
Thomas L. Ortel, MD, PhD, Michele Beckman, MPH, W Craig Hooper, PhD, Deborah A Lewis, PhD, Jen-Tsan A. Chi, MD., PhD, Kristy M. Kenney, MPH, Christine De Staercke, PhD, John A. Heit, M.D., Stephan Moll, MD, Claire S. Philipp, MD, Marilyn J. Manco-Johnson, MD
Blood (2011) 118 (21): 2305.
Daniel Landi, PhD, Michele Beckman, Nirmish Shah, MD, Paula Bockenstedt, John A. Heit, M.D., Roshni Kulkarni, MD, Marilyn Manco-Johnson, PhD, Stephan Moll, Claire S. Philipp, MD, Judith C. Andersen, MD, Thomas L. Ortel, MD, PhD
Blood (2010) 116 (21): 4219.
Risk for Post Thrombotic Syndrome (PTS) Development in Children with Extremity Deep Venous Thrombosis (DVT): Results of the US Centers for Disease Control and Prevention (CDC) Pediatric Thrombosis and Hemostasis Centers.
Marilyn J. Manco-Johnson, Michele G. Beckman, MPH, Neil A. Goldenberg, MD, PhD, Courtney Thornburg, MD, MS, Lisa A. Michaels, MD, Steven W. Pipe, MD, Stephan Moll, MD, Vilmarie Rodriquez, MD, Roshni Kulkarni
Blood (2009) 114 (22): 4000.
Clinical Trial of a Portable Electrical Muscle Stimulator (VeinoPlus®) to Improve Symptoms of Postthrombotic Syndrome.
Blood (2009) 114 (22): 4540.
International Normalized Ratio (INR) Determined by Plasma-Based Methods Versus Point-of-Care Instruments in Patients with Antiphospholipid Antibody Syndrome.
Blood (2009) 114 (22): 1067.
Lisa A Michaels, MD, Michele Beckman, MPH, Courtney Thornburg, MD, MS, Kristy Marquez, MPH, Roshni Kulkarni, MD, Steven W. Pipe, MD, Stephan Moll, MD, Marilyn Manco-Johnson, MD
Blood (2009) 114 (22): 2990.
Venous Thromboembolism (VTE) Characteristics among White- and Black-Americans: a Cross Sectional Study
John A. Heit, MD, Michele Beckman, MPH, Althea Grant, PhD, Nigel S. Key, MBChB, Marilyn J. Manco-Johnson, MD, Stephan Moll, MD, Paula Bockenstedt, MD, Roshni Kulkarni, MD, Thomas L. Ortel, MD, PhD, Claire S. Philipp, MD
Blood (2008) 112 (11): 3831.
Safety and Efficacy of Alfimeprase in Subjects with Occluded Central Venous Access Devices: The SONOMA-2 Study.
Stephan Moll, MD, Nashat Gabrail, MD, Jim Buchanan, PharmD, Mohammad Hirmand, MD, Michael Levy, MD, Ralph Zitnik, MD
Blood (2007) 110 (11): 1866.
Warfarin-Associated Calciphylaxis in a Patient without Renal Failure or Hyperparathyroidism: Investigation of the Matrix GLA Protein.
Rebecca Redman, MD, Caron P. Misita, PharmD, Darrell W. Stafford, PhD, David Sane, MD, Stephan Moll, MD
Blood (2005) 106 (11): 3969.
Safety and Efficacy of Alfimeprase for Restoring Function in Occluded Central Venous Catheters: Interim Results of a Phase 2, Multicenter, Randomized, Double-Blind Study (NuCath).
Steven R. Deitcher, MD, Stephan Moll, MD, Howard D. Homesley, MD, Luigi Bertoli, MD, Peter Kenyon, MD, Peter Swischuk, MD, Luis Pena
Blood (2004) 104 (11): 1768.
Thrombocytopenia Is More Common and Nadir Occurs Earlier with Unfractionated Heparin Than with Low Molecular Weight Heparin - Results from the Prospective Catch Registry.
Stephan Moll, MD, Charles S. Abrams, MD, Lawrence Rice, MD, Richard C. Becker, MD, Peter B. Berger, MD, Kevin J. Anstrom, Emily F. Honeycutt, Eric M. Crespo, MD, Chris Granger, MD, David J. Moliterno, MD, Jo E. Rodgers, pharmD, Steven R. Steinhubl, MD, Victor F. Tapson, MD, Magnus Ohman, MD
Blood (2004) 104 (11): 2197.